Pharmaceutical Technology Europe- February 2023

Pharmaceutical Technology Europe- February 2023

Issue link: https://www.e-digitaleditions.com/i/1492687

Contents of this Issue

Navigation

Page 9 of 32

10 Pharmaceutical Technology ® Bio/Pharma Outsourcing Innovation eBook 2023 PharmTech.com TON FORIO - STOCK.ADOBE.COM T he pace of quality transformation in life sci- ences continues to accelerate as global phar- maceutical companies and fast-growing bio- techs look to simplify and automate complex processes. Investments in technology are expected to continue well beyond 2023, with the quality manage- ment systems (QMS) market forecasted to grow at a 10% compound annual growth rate until 2030 (1). Industry leaders are driving positive change and charting the path toward unified quality processes that bring together people, partners, and systems. For exa mple, T he Center for Brea kt h rough Medi- cines is a contract development and manufacturing organization (CDMO) that adopted advanced quality solutions to support its vision of building the world's largest cell and gene therapy manufacturing and testing facility (2). However, more work remains to stay ahead of evolv- ing market conditions, reg ulator y requirements, a nd c u s tomer e x pe c t at ion s. A cont i nue d com- m i t m e n t t o d r i v i n g i n n o v a t i o n w i l l b e c r i t- i c a l f or c om p a n ie s t o k e e p u p w i t h i n d u s t r y changes and deliver new therapeutics to patients more qu ick ly wh i le m it igat i ng r isk s. I n t h is a r- t icle, four key t rends t hat w i l l shape t he f ut ure of q u a l i t y a n d m a nu f a c t u r i n g a r e i d e n t i f ie d , examined, and discussed. Quality will evolve from cost-center to value creator Quality has long been considered a necessar y cost center to en s u re produc t s meet m a nu f ac t u r i ng and regulator y requirements. The fragmented na- ture of systems and processes in quality has held it back, and the industr y has taken notice. More com- panies are now appointing chief quality officers to drive innovation across t he va lue chain, a signa l that qualit y management discussions are making it to the boardroom. Forecasting Trends in Pharma Innovation Ashley Wentworth is senior director, Vault Quality, at Veeva Systems. in the coming year, pharmaceutical innovation will be fueled by key trends throughout the quality sector.

Articles in this issue

Links on this page

Archives of this issue

view archives of Pharmaceutical Technology Europe- February 2023 - Pharmaceutical Technology Europe- February 2023